These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9278949)

  • 41. Effects of apomorphine on blood levels of homovanillic acid, growth hormone and prolactin in medicated schizophrenics and healthy control subjects.
    Scheinin M; Syvälahti EK; Hietala J; Huupponen R; Pihlajamäki K; Seppälä OP; Säkö E
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):441-9. PubMed ID: 2866563
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of L-DOPA on nigral dopamine neurons and local field potential: comparison with apomorphine and muscimol.
    Xu D; Karain B; Brantley E; Shi WX
    J Pharmacol Exp Ther; 2011 May; 337(2):533-9. PubMed ID: 21330359
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential effects of dopamine agonists and haloperidol on release of prolactin, thyroid stimulating hormone, growth hormone and luteinizing hormone in rats.
    Mueller GP; Simpkins J; Meites J; Moore KE
    Neuroendocrinology; 1976; 20(2):121-35. PubMed ID: 958594
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blunted response of growth hormone to clonidine and apomorphine in endogenous depression.
    Ansseau M; Von Frenckell R; Cerfontaine JL; Papart P; Franck G; Timsit-Berthier M; Geenen V; Legros JJ
    Br J Psychiatry; 1988 Jul; 153():65-71. PubMed ID: 3224252
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy.
    Ettigi P; Nair NP; Lal S; Cervantes P; Guyda H
    J Neurol Neurosurg Psychiatry; 1976 Sep; 39(9):870-6. PubMed ID: 993808
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Involvement of the presynaptic dopamine D2 receptor in the depression of spinal reflex by apomorphine.
    Gajendiran M; Seth P; Ganguly DK
    Neuroreport; 1996 Jan; 7(2):513-6. PubMed ID: 8730818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Longitudinal instability of hormone responses in schizophrenia.
    Cleghorn JM; Brown GM; Brown PJ; Kaplan RD; Mitton J
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):545-9. PubMed ID: 6686692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of hydrocortisone on basal and apomorphine-induced growth hormone secretion in normal subjects.
    Lal S; Nair NP; Isaac I; Guyda H; Quirion R
    Clin Invest Med; 1988 Jun; 11(3):218-23. PubMed ID: 3402107
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Apomorphine-induced activation of dopamine receptors modulates FGF-2 expression in astrocytic cultures and promotes survival of dopaminergic neurons.
    Li A; Guo H; Luo X; Sheng J; Yang S; Yin Y; Zhou J; Zhou J
    FASEB J; 2006 Jun; 20(8):1263-5. PubMed ID: 16636101
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suppression of prolactin by dopamine agonists in schizophrenics and controls.
    Rotrosen J; Angrist B; Clark C; Gershon S; Halpers FS; Sachar EJ
    Am J Psychiatry; 1978 Aug; 135(8):949-51. PubMed ID: 665840
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of the dopamine agonist, apomorphine, on regional cerebral blood flow in normal volunteers.
    Grasby PM; Friston KJ; Bench CJ; Cowen PJ; Frith CD; Liddle PF; Frackowiak RS; Dolan RJ
    Psychol Med; 1993 Aug; 23(3):605-12. PubMed ID: 7901864
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dopaminergic function in panic disorder: comparison with major and minor depression.
    Pitchot W; Ansseau M; Gonzalez Moreno A; Hansenne M; von Frenckell R
    Biol Psychiatry; 1992 Dec; 32(11):1004-11. PubMed ID: 1467380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Apomorphine-induced growth hormone response is attenuated by ethanol but not dextromethorphan.
    Budde H; Zimmermann US; Steffin B; Rommelspacher H; Schmidt LG; Smolka MN
    Alcohol Clin Exp Res; 2007 Jan; 31(1):100-3. PubMed ID: 17207107
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison of the growth hormone responses to clonidine and apomorphine in the same patients with endogenous depression.
    Corn TH; Hale AS; Thompson C; Bridges PK; Checkley SA
    Br J Psychiatry; 1984 Jun; 144():636-9. PubMed ID: 6743929
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhanced apomorphine sensitivity and increased binding of dopamine D2 receptors in nucleus accumbens in prepubertal rats after neonatal blockade of the dopamine D3 receptors by (+)-S14297.
    Flores-Tochihuitl J; Vargas G; Morales-Medina JC; Rivera G; De La Cruz F; Zamudio S; Flores G
    Synapse; 2008 Jan; 62(1):40-9. PubMed ID: 17957737
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The dopamine agonist apomorphine enhances conditioned pain modulation in healthy humans.
    Treister R; Pud D; Eisenberg E
    Neurosci Lett; 2013 Aug; 548():115-9. PubMed ID: 23727387
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relation of clinical symptoms to apomorphine-stimulated growth hormone release in mood-incongruent psychotic patients.
    Zemlan FP; Hirschowitz J; Garver DL
    Arch Gen Psychiatry; 1986 Dec; 43(12):1162-7. PubMed ID: 3778112
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dopamine electrophysiology of ventral pallidal/substantia innominata neurons: comparison with the dorsal globus pallidus.
    Napier TC; Simson PE; Givens BS
    J Pharmacol Exp Ther; 1991 Jul; 258(1):249-62. PubMed ID: 1677041
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of dopamine agonists on Cebus apella monkeys with previous long-term exposure to fluphenazine.
    Lifshitz K; O'Keeffe RT; Linn GS; Lee KL; Camp-Bruno JA; Suckow RF
    Biol Psychiatry; 1997 Mar; 41(6):657-67. PubMed ID: 9066989
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuroendocrine evaluation of CCK-peptides on dopaminergic function in man.
    Lal S; Nair NP; Eugenio H; Thavundayil J; Lizondo E; Wood PL; Etienne P; Guyda H
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):537-44. PubMed ID: 6320299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.